Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Medication

Medication Recalls

Browse drug and medication recalls including prescription drugs, OTC medications, and supplements. Stay informed about pharmaceutical safety alerts.

Get alerts for medication RSS feed

Showing 961–980 of 1639 recalls

Filter by date, severity, state →

Levofloxacin Ophthalmic Solution 0.5% (Akorn) – Business Closure Stability Issue (2023)

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Class IIModerate

FDAApr 26, 2023Nationwide• Akorn, Inc.

Lorazepam Injection (Akorn) – Stability Study Halt (2023)

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Class IIModerate

FDAApr 26, 2023Nationwide• Akorn, Inc.

Sulfamethoxazole & Trimethoprim Suspension (Akorn) – Stability Studies Discontinued (2023)

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Class IIModerate

FDAApr 26, 2023Nationwide• Akorn, Inc.

Dicyclomine Hydrochloride Injection 20mg (Akorn) – Business Closure Stability Issue (2023)

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Class IIModerate

FDAApr 26, 2023Nationwide• Akorn, Inc.

AK-POLY-BAC Ophthalmic Ointment (Akorn) – Business Closure Stability Issue (2023)

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Class IIModerate

FDAApr 26, 2023Nationwide• Akorn, Inc.

Ciclopirox Topical Solution (Akorn) – Stability Study Halt (2023)

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Class IIModerate

FDAApr 26, 2023Nationwide• Akorn, Inc.

Albuterol Sulfate Syrup (Akorn) – CGMP Deviation (2023)

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Class IIModerate

FDAApr 26, 2023Nationwide• Akorn, Inc.

Hydrocortisone and Acetic Acid Otic Solution (Akorn) – Stability Studies Discontinued (2023)

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Class IIModerate

FDAApr 26, 2023Nationwide• Akorn, Inc.

Calcitriol Injection 1mcg/mL (Akorn) – Business Closure Stability Issue (2023)

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Class IIModerate

FDAApr 26, 2023Nationwide• Akorn, Inc.

Naloxone Injection (Akorn) – Stability Study Halt (2023)

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Class IIModerate

FDAApr 26, 2023Nationwide• Akorn, Inc.

XOPENEX Inhalation Solution (Akorn) – Stability Study Halt (2023)

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Class IIModerate

FDAApr 26, 2023Nationwide• Akorn, Inc.

Sufenta Injection (Akorn) – Stability Studies Discontinued (2023)

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Class IIModerate

FDAApr 26, 2023Nationwide• Akorn, Inc.

Azelastine Hydrochloride Nasal Spray 0.15% (Akorn) – Business Closure Stability Issue (2023)

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Class IIModerate

FDAApr 26, 2023Nationwide• Akorn, Inc.

Rifampin Capsules 300mg (Akorn) – Business Closure Stability Issue (2023)

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Class IIModerate

FDAApr 26, 2023Nationwide• Akorn, Inc.

Lidocaine Patch (Bryant Ranch) – Labeling Error (2023)

Labeling: Typographical error on the upper left-hand side of the box and individual patch label that has the incorrect dosage form stating, each tablet contains instead of each adhesive patch contains.

FDAApr 20, 2023Nationwide• Bryant Ranch Prepack, Inc.

C-Semaglutide Injection (Vital Care) – Sterility Concern (2023)

Lack of assurance of sterility.

Class IIModerate

FDAApr 13, 2023MS• Pharmacy Plus, Inc. dba Vital Care Compounder

Admelog (Sanofi-Aventis) – Sterility Seal Issue (2023)

Lack of Assurance of Sterility: Malformed crimped collar seal

Class IIModerate

FDAApr 11, 2023Nationwide• Sanofi-Aventis U.S. LLC

Advil Ibuprofen Tablets (Family Dollar) – Storage Temperature Issue (2023)

CGMP deviation: product outside labeled storage temperature requirements.

Class IIModerate

FDAMar 31, 2023Nationwide• Family Dollar Stores, Llc.

Advil Dual Action (Family Dollar) – Storage Temperature Issue (2023)

CGMP deviation: product outside labeled storage temperature requirements.

Class IIModerate

FDAMar 31, 2023Nationwide• Family Dollar Stores, Llc.

Advil Ibuprofen Tablets (Family Dollar) – Storage Temperature Issue (2023)

CGMP deviation: product outside labeled storage temperature requirements.

Class IIModerate

FDAMar 31, 2023Nationwide• Family Dollar Stores, Llc.

1...47 484950 51...82

Page 49 of 82Next

Browse Other Categories

Food Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other